MedPath
HSA Approval

Potassium Chloride 0.30% in Dextrose 5% and Sodium Chloride 0.45% Injection USP

SIN13889P

Potassium Chloride 0.30% in Dextrose 5% and Sodium Chloride 0.45% Injection USP

Potassium Chloride 0.30% in Dextrose 5% and Sodium Chloride 0.45% Injection USP

November 12, 2010

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

B05BB01

electrolytes

Manufacturer Information

B. Braun Singapore Pte Ltd.

B.Braun Medical Inc. (Parametric release)

Active Ingredients

Hydrous Dextrose

50g/1000ml

Glucose

Sodium Chloride

4.5g/1000ml

Sodium chloride

Potassium Chloride

3.0g/1000ml

Potassium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Potassium Chloride 0.30% in Dextrose 5% and Sodium Chloride 0.45% Injection USP - HSA Approval | MedPath